0 التعليقات
0 المشاركات
513 مشاهدة
0 معاينة
البحث
إكتشاف أشخاص جدد وإنشاء اتصالات جديدة وصداقات جديدة
- الرجاء تسجيل الدخول , للأعجاب والمشاركة والتعليق على هذا!
- Antihyperlipidemic Drugs Market Size, Share, Trends 2024-2032IMARC Group, a leading market research company, has recently releases report titled “Antihyperlipidemic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032.” The study provides a detailed analysis of the industry, including the global antihyperlipidemic drugs market size, growth, share, trends, and forecasts. The report also includes...0 التعليقات 0 المشاركات 1415 مشاهدة 0 معاينة
- Antihyperlipidemic Drugs Market, analysis Outlook, Trend, Growth And Share Estimation Analysis To 2031The global Antihyperlipidemic Drugs market is estimated to attain a valuation of US$ 20.1 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 6.1% during the forecast period, 2022-2031. The key objective of the TMR report is to offer a complete assessment of the global market...0 التعليقات 0 المشاركات 2014 مشاهدة 0 معاينة
- Antihyperlipidemic Drugs: Effective medications to manage high cholesterol levelsHyperlipidemia or high cholesterol is a condition where excessive amounts of lipids (fats) accumulate in the blood. This can increase the risks of cardiovascular diseases like heart attack and stroke. Lifestyle modifications like dietary changes and exercise can help control cholesterol levels to some extent. However, medications are often required to bring cholesterol values down to the...0 التعليقات 0 المشاركات 1770 مشاهدة 0 معاينة
- Global Antihyperlipidemic Drugs Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Cardiovascular DiseasesThe Antihyperlipidemic Drugs Market is estimated to be valued at US$ 12.6 Bn in 2022 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview: Antihyperlipidemic drugs are used to lower and control the levels of lipids, such as cholesterol and triglycerides, in the blood. These drugs are...0 التعليقات 0 المشاركات 1324 مشاهدة 0 معاينة
- Managing Dyslipidaemia With Antihyperlipidemic DrugsStatins are the first-line therapy for lowering LDL-C and total cholesterol levels. Statins work by inhibiting HMG-CoA reductase, a liver enzyme involved in cholesterol synthesis. This inhibition leads to upregulation of LDL receptors in the liver, enhancing clearance of LDL from the blood. Some commonly prescribed statins include atorvastatin, rosuvastatin, simvastatin, and pravastatin....0 التعليقات 0 المشاركات 489 مشاهدة 0 معاينة
- Pharmaceutical Drugs (Statins) Is The Largest Segment Driving The Growth Of Antihyperlipidemic Drugs MarketSWOT Analysis Strengths: Drugs in this market such as statins are highly effective in lowering LDL cholesterol levels and reducing the risk of heart attacks and strokes. The market comprises several major pharmaceutical players with wide distribution networks. Weaknesses: Statins have certain side effects such as muscle pain and are not suitable for all patients. Generic competition has eroded...0 التعليقات 0 المشاركات 1274 مشاهدة 0 معاينة
- The Antihyperlipidemic Drugs Market is poised to witness high growth owing to Increasing Prevalence of ObesityThe global Antihyperlipidemic Drugs Market is estimated to be valued at US$ 13.6 Bn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Antihyperlipidemic drugs are commonly known as lipid lowering drugs or statins which reduce cholesterol and triglyceride levels in the blood. These...0 التعليقات 0 المشاركات 1025 مشاهدة 0 معاينة